Department of Tobacco Control and Prevention of Respiratory Diseases, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, China.
WHO Collaborating Center for Tobacco Cessation and Respiratory Diseases Prevention, Beijing, China.
BMC Public Health. 2024 Aug 1;24(1):2086. doi: 10.1186/s12889-024-19510-w.
To our knowledge, there is no available nationwide data on omicron symptom patterns in China mainland. We aim to determine the acute and long COVID-19 symptoms in the omicron-dominant period and to evaluate its association with risk factors.
We designed a cross-sectional nationwide study and data about self-reported symptoms were collected by an online platform named Wenjuanxing. Eligible participants were aged 25-65 years and were symptomatic. In this study, the ratios of the number of people of different ages and genders were weighted by the data from the Seventh National Census (2020 years), and validated by a published nationwide representative study through comparing smoking rates. Descriptive indicators were calculated for demographic characteristics, diagnosis ways, and duration time, acute symptoms, hospitalization, severity and long COVID-19 symptoms. And, the associations between risk factors and acute and long COVID-19 symptoms were analyzed by multivariable logistic regression models.
A total of 32,528 individuals diagnosed as COVID-19 infection from October 1, 2022 to February 21, 2023 were included. The first three acute symptoms of COVID-19 infection were fever (69.90%), headache (62.63%), and sore throat (54.29%), respectively. The hospitalization rate within 7 days was 3.07% and symptoms disappearance rate within 21 days was 68.84%, respectively. Among 3983 COVID-19 patients with 3 months or more time difference between first infection and participation into the study, the long COVID-19 rate was 19.68% and the primary symptoms were muscle weakness (19.39%), headache (17.98%) and smell/taste disorder (15.18%). Age groups, smoking, marriage status and vaccination were risk factors for numbers of acute phase symptoms and long COVID-19 symptoms. Lastly, female and current smokers also showed more numbers of symptoms during acute infection period.
In Chinese mainland, our respondent indicated that current smokers and women were associated with acute COVID-19 symptoms, which should be treated with caution due to the lack of representative.
据我们所知,目前中国内地还没有关于奥密克戎症状模式的全国性数据。我们旨在确定奥密克戎主导时期的急性和长期 COVID-19 症状,并评估其与危险因素的关系。
我们设计了一项全国性的横断面研究,通过一个名为问卷星的在线平台收集自我报告的症状数据。合格的参与者年龄在 25-65 岁之间,有症状。在这项研究中,不同年龄和性别的人数比例通过 2020 年第七次全国人口普查的数据进行加权,并通过与一项已发表的全国代表性研究比较吸烟率进行验证。计算了人口统计学特征、诊断方法和持续时间、急性症状、住院、严重程度和长期 COVID-19 症状的描述性指标。并通过多变量逻辑回归模型分析了危险因素与急性和长期 COVID-19 症状的关系。
共纳入 2022 年 10 月 1 日至 2023 年 2 月 21 日期间确诊为 COVID-19 感染的 32528 人。COVID-19 感染的前三种急性症状分别是发热(69.90%)、头痛(62.63%)和喉咙痛(54.29%)。7 天内住院率为 3.07%,21 天内症状消失率为 68.84%。在 3983 名 COVID-19 患者中,有 3983 名患者在首次感染和参与研究之间的时间差为 3 个月或以上,长期 COVID-19 发生率为 19.68%,主要症状为肌肉无力(19.39%)、头痛(17.98%)和嗅觉/味觉障碍(15.18%)。年龄组、吸烟、婚姻状况和疫苗接种是急性和长期 COVID-19 症状数量的危险因素。最后,女性和当前吸烟者在急性感染期也表现出更多的症状。
在中国内地,我们的受访者表示,当前吸烟者和女性与急性 COVID-19 症状有关,由于缺乏代表性,应谨慎对待。